NetworkNewsWire Editorial Coverage Artificial intelligence (AI) is making inroads into every corner of medical technology, perhaps none more urgently than imaging. In breast cancer detection, where early diagnosis can mean the difference between life and death, AI-enhanced modalities present a chance to leap beyond the limits of mammography,tomosynthesis, and MRI. Globally, breast cancer remains one […]
AudioEye, Inc.(Nasdaq: AEYE) (“AudioEye” or the “Company”), the industry-leading digital accessibility company, will hold a conference call on Tuesday, November 4, 2025 at 4:30 p.m. Eastern Time to discuss its financial results for the third quarter ended September 30, 2025. Financial results will be issued in a press release prior to the call. https://mma.prnewswire.com/media/1470477/AudioEye_v3_Logo.jpg AudioEye
374Water Completes Commercial-Scale Field Demonstration for DoD ESTCP/DIU Project GlobeNewswire October 21, 2025 Executed PFAS Destruction of Multiple Concentrated Waste Streams at Commercial TSDF using AirSCWO(TM) 6 System Final Report to be Released by Q1 2026 DURHAM, N.C., Oct. 21, 2025 (GLOBE NEWSWIRE) — 374Water Inc. (NASDAQ: SCWO) (“374Water” or the “Company”), a global leader
Discover how Foxit's intelligent PDF and eSignature tools help educators, administrators, and students simplify workflows, boost collaboration, and accelerate digital learning Foxit, a leading provider of innovative PDF and eSignature products and services that help knowledge workers increase productivity and do more with documents, will showcase its latest education-focused document solutions at EDUCAUSE 2025. https://mma.prnewswire.com/media/2620217/new_foxit_Logo_2025.jpg
Revalesio, a clinical-stage pharmaceutical company pioneering neuroprotective therapies for neurological disorders, today announced that data from a post hoc analysis of the RESCUE Phase 2 clinical trial of its investigational drug RNS60 will be featured as one of two promising drug candidates for the treatment of stroke in an upcoming session at the 17th World
Talphera, Inc.(Nasdaq: TLPH), (Talphera), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the appointment of Joe Todisco, the CEO of CorMedix Inc. (Nasdaq: CRMD) to its Board of Directors. In September 2025, CorMedix made a strategic investment in Talphera as part of
Nearly Three Out of Four IT and Industry Leaders Now Prioritize Revenue Growth as Main Driver of AI Initiatives, Over Cost Savings and Increased Customer Satisfaction ePlus inc. (NASDAQ: PLUS) today announced the findings of its new AI Industry Pulse Poll, which offers a closer look at how organizational leaders are reimagining the role of
RTX Fintech & Research (“RTX Fintech”), a leading US electronic interdealer trading platform for interest rate swaps, today announced the appointment of André Léger as Chief Product Officer and Head of Markets, Asia. Léger will be responsible for driving RTX's end-to-end product development and global platform roadmap, while enhancing platform functionality through integrated market research
IAB NewFronts Moves to March to Align with Buyer Demand Fall 2026 Lineup Combines IAB PlayFronts, IAB Podcast Upfront, and Launches First-EverIAB CreatorFronts Across a Single Week Today the Interactive Advertising Bureau (IAB), the leading trade body for the digital advertising industry, unveiled strategic changes to its 2026 calendar of marketplace events, reinforcing its commitment
In this free webinar, gain insights about the differences between GMP and USP compounding in research. Attendees will learn that although USP can support certain research needs, it falls short when robust data integrity, reproducibility and regulatory compliance are required, particularly in early phase clinical trials. The featured speakers will share real-world case studies, where